GSK Investigational Site

Scarborough Village, Ontario M1W 3W3

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerosis, Deep Vein Thrombosis, Fibrillation, Atrial, Lung Cancer, Non-Small Cell, Neoplasms, Prostate, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
• A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) — Completed
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men — Completed